Advertisement
Screener

Lion Point Capital, LP Historic Quarter Change: USA Other Stocks, New

Lion Point Capital, LP historic quarter change: USA Other Stocks, New

In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 13 quarters from 2015-12-31 to 2026-06-30, Lion Point Capital, LP opened 8 positions, added to 5, reduced 7 and sold out of 16.

  • Q4 2025: Stock CUE BIOPHARMA INC; Country of operation United States; Class COM; Shares before 0.
  • Q1 2025: Stock MERSANA THERAPEUTICS INC; Country of operation United States; Class COM; Shares before 0.
  • Q4 2024: Stock BLUEBIRD BIO INC; Country of operation United States; Class COM NEW; Shares before 0.
  • Q1 2024: Stock SPRUCE BIOSCIENCES INC; Country of operation United States; Class COM; Shares before 0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1643354), 13 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2015-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q4 2025CUE BIOPHARMA INC
CUSIP 22978P106
United StatesCOM02,202,854+2,202,854$0$672,752+$672,7522026-02-17
Q1 2025MERSANA THERAPEUTICS INC
CUSIP 59045L106
United StatesCOM0644,000+644,000$0$221,665+$221,6652025-05-15
Q4 2024BLUEBIRD BIO INC
CUSIP 09609G209
United StatesCOM NEW078,912+78,912$0$658,126+$658,1262025-02-14
Q1 2024SPRUCE BIOSCIENCES INC
CUSIP 85209E109
United StatesCOM075,000+75,000$0$58,943+$58,9432024-05-15
Q3 2016YAHOO INC
CUSIP 984332106
COM0350,000+350,000$0$15,085,000+$15,085,0002016-11-14
Q3 2016HORIZON PHARMA PLC
CUSIP G4617B105
SHS0250,000+250,000$0$4,532,000+$4,532,0002016-11-14
Q2 2016HRG GROUP INC
CUSIP 40434J100
COM03,667,855+3,667,855$0$50,359,000+$50,359,0002016-08-15
Q2 2016MARVELL TECHNOLOGY GROUP LTD
CUSIP G5876H105
ORD02,000,000+2,000,000$0$19,060,000+$19,060,0002016-08-15

Similar Firms

Firm NameCountry13F ValueHoldings
Clal Insurance Enterprises Holdings LtdIsrael$0.017B214
PPM AMERICA INC/ILUnited States$0.017B5
Prossimo Advisors, LLCUnited States$0.016B24
SWISS RE LTDSwitzerland$0.016B239
Samsung C&T CorpSouth Korea$0.017B1
Summit Rock Advisors, LPUnited States$0.016B1
Covalent Partners LLCUnited States$0.018B16
BP PLCUnited Kingdom$0.018B1
Curative Ventures V LLCUnited States$0.016B1
Bain Capital Public Equity, LPUnited States$0.018B20